Phospho-ERK1/2 Single-Cell Quantification by Intracellular Phospho-Flow Cytometry Following EGF Stimulation in MDA-MB-231 Breast Cancer Cells

EGF time course (0, 2, 5, 10, 30, 60 min at 50 ng/mL) and a dose sub-series (0, 1, 10, 50 ng/mL at the peak time point), each n=3 independent biological replicates. Per condition, ≥10,000 single-cell events are recorded. An unstimulated and a phosphatase-inhibitor-only control bound the dynamic range. Tube acquisition order is randomized; a single staining master mix is used per replicate to control antibody variability. Compensation/gating is performed blinded to condition labels.

BSL-2 for MDA-MB-231 cells; biosafety cabinet for live-cell work. Formaldehyde is a carcinogen—use in a fume hood, nitrile gloves, eye protection; collect formaldehyde/methanol waste as flammable hazardous waste. Methanol is flammable—keep away from ignition, store on ice. PMA is a tumor promoter—handle with care, dedicated tips. Decontaminate live-cell waste in 10% bleach 30 min; fixed-cell waste is non-infectious but contains formaldehyde. Operate the cytometer per BSL-2 aerosol-containment guidance.

Negative/baseline: unstimulated serum-starved cells (basal p-ERK). Isotype control (AF647 IgG1) defines non-specific antibody background and sets the positive gate. Positive control: PMA (direct PKC/MAPK activator) confirms staining and instrument sensitivity. Fluorescence-minus-one (FMO) for the viability dye sets the live gate. An unstained tube establishes autofluorescence. A vehicle (PBS) stimulation arm controls for handling-induced signaling.

Basal p-ERK MFI is low after starvation; EGF induces a 3-8 fold MFI increase peaking at 5-10 min, declining by 60 min. The dose-response shows graded MFI with increasing percent-positive cells. PMA gives strong, sustained signal. Isotype MFI sits at baseline. At intermediate EGF (1-10 ng/mL), expect a widened or bimodal single-cell distribution (responder fraction 30-70%).

• MDA-MB-231 cells (ATCC HTB-26), triple-negative breast cancer
• DMEM high glucose + 10% FBS + 1% pen/strep; serum-free DMEM for starvation
• Recombinant human EGF, 10 µg/mL stock, used at 1-50 ng/mL
• 16% methanol-free formaldehyde (final 1.5%)
• Ice-cold 100% methanol (permeabilization)
• Cell staining buffer (PBS + 0.5% BSA + 2 mM EDTA)
• Anti-phospho-ERK1/2 (Thr202/Tyr204) (E10) mouse mAb, Alexa Fluor 647-conjugated, 1:50
• Isotype control: AF647 mouse IgG1, matched concentration
• Fixable viability dye (e.g., Zombie Aqua), 1:500
• 5 mL polystyrene round-bottom FACS tubes; 70 µm filters
• PMA (positive-control stimulus), 100 ng/mL

To establish a fixation/permeabilization phospho-flow workflow that measures phospho-ERK1/2 in individual MDA-MB-231 cells across an EGF stimulation time course, capturing both population-level fold-induction and single-cell heterogeneity (percent responders, distribution width) that bulk Western blot cannot resolve. The method provides a per-cell, quantitative MAPK activation readout.

1. Seed MDA-MB-231 at 1 x 10^6 per condition; serum-starve 16 h in serum-free DMEM to lower basal ERK.
2. Warm EGF dilutions; stimulate cells at 37 °C for the assigned time (0-60 min); a PMA arm (100 ng/mL, 15 min) as positive control.
3. Stop reactions by adding pre-warmed formaldehyde directly to medium to 1.5% final; fix 10 min at 37 °C.
4. Pellet 300 x g 5 min; resuspend and stain viability dye 15 min on ice (if pre-fix viability desired, do before fixation).
5. Permeabilize by adding ice-cold 100% methanol dropwise while vortexing; incubate 30 min on ice (or -20 °C overnight).
6. Wash 2x with staining buffer, 600 x g 5 min (higher speed—methanol-fixed cells).
7. Stain with AF647 anti-p-ERK (or isotype) 1 h at RT in the dark.
8. Wash 2x; resuspend in 300 µL staining buffer; filter into FACS tubes.
9. Acquire ≥10,000 single live cells per tube on a flow cytometer; record median fluorescence intensity (MFI).
10. Run unstained and isotype tubes for gating/background each session.

Independent variables: EGF concentration (0-50 ng/mL) and stimulation time (0-60 min). Dependent variables: p-ERK1/2 MFI (population) and percent p-ERK-positive cells plus distribution coefficient of variation (single-cell). Controlled variables: starvation duration (16 h), fixation timing/temperature, methanol permeabilization (30 min), antibody dilution (1:50), event count (≥10,000), and instrument PMT voltages (set once and locked across the experiment).

We hypothesize that EGF stimulation drives rapid, transient ERK1/2 phosphorylation peaking at 5-10 min and declining by 60 min, and that the single-cell phospho-ERK distribution is bimodal/heterogeneous at intermediate EGF doses—revealing a switch-like responder fraction not apparent in averaged immunoblot data.

Analyze FCS files in FlowJo: gate singlets (FSC-H vs FSC-A), live cells (viability-dye-negative), then quantify p-ERK MFI and percent-positive relative to the isotype gate. Compute fold-change MFI = (sample - isotype)/(unstimulated - isotype). Export per-cell intensities to assess distribution metrics (CV, percent responders). Plot kinetic and dose curves; fit the dose-response to a four-parameter logistic for EC50.

1. No EGF response: ensure full serum starvation and that EGF is freshly diluted (degrades on freeze-thaw); verify cells were warm during stimulation. 2. High background/no separation: methanol permeabilization is essential for nuclear/cytoplasmic phospho-epitopes—do not substitute saponin; titrate antibody. 3. Cell clumping after methanol: add EDTA to buffers, filter before acquisition, increase wash speed to 600 x g. 4. Weak PMA control: check fixation timing—delayed fixation lets phospho-signal decay. 5. Shifted populations across days: lock PMT voltages and use calibration beads to standardize MFI.

n=3 biological replicates. For the time course, use repeated-measures one-way ANOVA with Dunnett's correction vs t=0 (alpha = 0.05); for the dose-response, one-way ANOVA + Dunnett's and a 4PL EC50 with 95% CI. Compare single-cell CVs between conditions by paired t-test. Report exact p-values and eta-squared. Power: with expected large fold-changes (Cohen's d > 1.5), n=3 yields >0.8 power for the primary kinetic contrast.